ATAI vs EFX · rev $4.1M vs P/E 54, rev $3.35B
ATAI Life Sciences BV (ATAI) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
ATAI currently screens at market cap $555.8M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the ATAI and EFX stock pages for the full models.
Not investment advice.